Condition: Chronic Liver Disease and Cirrhosis · Chronic Liver Disease · Portal Hypertension · Sponsor: Karl Landsteiner University of Health Sciences
This study looks to gather data on hepatomiR, a CE-certified test already intended for gauging liver-related outcomes, in order to define a cut-off regarding specific decompensation events (ascites, variceal hemorrhage, hepatic encephalopathy) in chronic liver disease (CLD). Based on these data, it is aimed to advance the current understanding of factors driving decompensation, with potential repercussions for future risk management and therapy.
This description comes directly from the study's public registry record.
Lukas Erhart, Mag. Dr. · 00432742900412311 · lukas.erhart@stpoelten.lknoe.at
Always discuss trial participation with your own doctor first.
| University Hospital St. Pölten | Sankt Pölten, Lower Austria, Austria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06432582